Detalhe da pesquisa
1.
The CIpP activator, TR-57, is highly effective as a single agent and in combination with venetoclax against CLL cells in vitro.
Leuk Lymphoma
; 65(5): 585-597, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38227293